Traditional Chinese medicinal composition for treating bronchitis and bronchial asthma

Abstract

The invention discloses a traditional Chinese medicinal composition for treating bronchitis and bronchial asthma. The composition is characterized in that the composition comprises, by weight, 12 parts of Cordyceps sinensis, 15 parts of Radix Codonopsis, 15 parts of Rhizoma Atractylodis Macrocephalae (stir-fried with bran), 15 parts of Poria cocos, 10 parts of Radix Ophiopogonis, 12 parts of Malaytea Scurfpea Fruit (stir-fried with salt), 10 parts of Chinese magnoliavine (processed with vinegar), 12 parts of Chinese angelica, 9 parts of Rhizoma Pinelliae Preparatum, 12 parts of snakegourd peel, 9 parts of bitter apricot kernel, 9 parts of Rhizoma Coptidis, 6 parts of jujube, 10 parts of perilla fruit, 10 parts of Aster tataricus, 10 parts of lily, 6 parts (calcined) gypsum, 9 parts of Cortex Magnoliae Officinalis, 10 parts of Radix Peucedani, 6 parts of dried orange peel, 9 parts of Chinese Eaglewood, 6 parts of ginger, 9 parts of loquat leaf, 10 parts of Fritillaria cirrhosa, 12 parts of prepared rehmannia root, 10 parts of Radix Scrophulariae, 6 parts of Arisaema Cum Bile, 10 parts of Radix Platycodonis, 10 parts of White Mulberry Root-bark (processed with honey), 9 parts of Rhizoma Anemarrhenae, 12 parts of Common Coltsfoot Flower, 15 parts of honeysuckle flower, 12 parts of Herba Schizonepetae, 12 parts of Weeping Forsythia and 6 parts of honey-fried licorice root.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating the respiratory system, in particular to a traditional Chinese medicine composition for treating chronic bronchitis and bronchial asthma. Background technique [0002] Bronchitis is a chronic inflammatory respiratory disease with complex etiology. Its clinical symptoms are wheezing, coughing, shortness of breath, and chest tightness. It often has a history of repeated attacks of asthma for many years. Diagnostic criteria for chronic bronchitis: 1. Acute attack stage refers to the occurrence of purulent or mucopurulent sputum within 1 week, with a significant increase in sputum volume, or accompanied by inflammatory manifestations such as fever, or any symptoms of cough, sputum, or wheezing within 1 week. Significant aggravation of symptoms, or significant aggravation of critically ill patients. 2. The chronic protracted stage refers to those who have symptoms of cough, ph...

AI Technical Summary

Problems solved by technology

The above treatment methods all temporarily relieve the symptoms of chronic bronchitis and bronchial asthma, but cannot completely cure chronic bronchitis and bronchial asthma